SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lefevre, P.A.
Right arrow Articles by Ashby, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lefevre, P.A.
Right arrow Articles by Ashby, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Evaluation of the Genetic Toxicity of the Peroxisome Proliferator and Carcinogen Methyl Clofenapate, Including Assays Usin Muta TM Mouse and Big BlueTM Transgenic Mice

P.A. Lefevre

Zeneca Central Toxicology Laboratory, Alderley Park, Cheshire, UK

H. Tinwell

Zeneca Central Toxicology Laboratory, Alderley Park, Cheshire, UK

S.M. Galloway

Merck Research Laboratories, West Point, Pennsylvania 19486, USA

R. Hill

Merck Research Laboratories, West Point, Pennsylvania 19486, USA

J.M. Mackay

Zeneca Central Toxicology Laboratory, Alderley Park, Cheshire, UK

C.R. Elcombe

Zeneca Central Toxicology Laboratory, Alderley Park, Cheshire, UK

J. Foster

Zeneca Central Toxicology Laboratory, Alderley Park, Cheshire, UK

V. Randall

Zeneca Central Toxicology Laboratory, Alderley Park, Cheshire, UK

R.D. Callander

Zeneca Central Toxicology Laboratory, Alderley Park, Cheshire, UK

J. Ashby

Zeneca Central Toxicology Laboratory, Alderley Park, Cheshire, UK

The rodent liver carcinogen and hepatic peroxisome proliferator methylclofenapate (MCP) has been evaluated for genetic toxicity in a range of in vitro and rodent genotoxicity assays. It gave a negative response in each of the following assays: mutagenicity to S.typhimurium and E.coli (± S9 mix, plate and pre-incubation assays), clastogenicity to cultured human lymphocytes and CHO cells (± S9 mix), a mouse bone marrow micronucleus assay (24h and 48h sampling), a rat liver assay for UDS in vivo (12h sampling), assays for lac I (Big BlueTM) and lac Z (MutaTM Mouse) mutations in the liver of transgenic mice, and an assay of the ability of MCP to modify the mutagenicity to the liver of dimethylnitrosamine in both transgenic mutation assays. The micronucleus and UDS assays were conducted using a single administration of MCP at its maximum tolerated dose, while the transgenic assays were conducted using nine daily administrations of MCP at its cancer bioassay dose level. These nine daily administrations were shown to double the weight of the liver of non-transgenic, Big BlueTM and MutaTM Mice, as well as leading to a dramatic proliferation of peroxisomes (electron microscopy) in the livers of each strain. These changed parameters had returned to control levels when the mutation analyses were conducted (10 days after the final dose of MCP). Despite the liver enlargement observed following MCP administration, no evidence of mitotic activity was observed in treated livers, although an increased number of cells were undergoing replicative DNA synthesis during the final 3 days of the 9 days of administration (BUdR assessment of S-phase). Liver biochemistry parameters (ALT, AST, AP, CK, GGT and albumin) were unaffected by the chronic (9 day) administration of MCP indicating an absence of hepatic toxicity, These combined observations favour a non-genotoxic mechanism of action for the hepatic carcinogenicity of MCP.

The clastogenicity in vitro of the peroxisome proliferator Wyeth 14,643 has been confirmed in CHO cells, but it is noted that this chemical is more soluble than is MCP. In particular, at the highest dose level at which MCP could be tested, Wy 14,643 was also nonclastogenic.

Human & Experimental Toxicology, Vol. 13, No. 11, 764-775 (1994)
DOI: 10.1177/096032719401301105


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
N. D. Lalwani, L. A. Dethloff, J. R. Haskins, D. G. Robertson, and F. A. De La Iglesia
Increased Nuclear Ploidy, Not Cell Proliferation, Is Sustained in the Peroxisome Proliferator-Treated Rat Liver
Toxicol Pathol, March 1, 1997; 25(2): 165 - 176.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
J. Ashby, L. Kier, A. Wilson, T. Green, P. Lefevre, H. Tinwell, G. Willis, W. Heydens, and M. Clapp
Evaluation of the potential carcinogenicity and genetic toxicity to humans of the herbicide acetochlor
Human and Experimental Toxicology, September 1, 1996; 15(9): 702 - 735.
[Abstract] [PDF]



Advertisement